Chronic chagasic cardiomyopathy involves infection-associated events that compromise microvasculature function and result in hypoperfusion, sharing abnormalities with other congestive cardiomyopathies.
Chronic chagasic cardiomyopathy is driven by microvascular dysfunction and hypoperfusion, sharing mechanisms with other chronic congestive cardiomyopathies.
The evidence gained from both human and animal studies of chronic chagasic cardiomyopathy suggests that the disease occurs as a consequence of several discrete and progressive pathophysiological processes occurring after infection, the ultimate expression of which depends on a host of unidentified factors. Collectively, the infection-associated events compromise microvasculature function and result in hypoperfusion, with consequences indistinguishable from those observed in other, nonparasitological cardiomyopathic diseases secondary to hypoperfusion. Therefore, chronic chagasic cardiomyopathy may share similar pathophysiological abnormalities with other chronic congestive cardiomyopathic states.
Morris et al. (Sat,) conducted a review in Chronic chagasic cardiomyopathy. Chagas' disease infection was evaluated. Chronic chagasic cardiomyopathy involves infection-associated events that compromise microvasculature function and result in hypoperfusion, sharing abnormalities with other congestive cardiomyopathies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: